Correction to: Cancer Cell Int (2017) 17:103 https://doi.org/10.1186/s12935-017-0473-z
Upon publication of the original article [1] it was highlighted by the authors that a grant awarded to support the research work of the study was missed in the Funding Acknowledgements of their manuscript. It should also be acknowledged that the grant titled “Shenzhen healthcare research project” (201505025 to Youde Liang) also contributed to the resources for this research. This has since been formally noted in this correction article.
Reference
Chen DC, Liang YD, Peng L, Wang YZ, Ai CZ, Zhu XX, Yan YW, Saeed Y, Yu B, Huang J, Gao Y. CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma. Cancer Cell Int. 2017;17(1):103. https://doi.org/10.1186/s12935-017-0473-z.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Chen, DC., Liang, YD., Peng, L. et al. Correction to: CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma. Cancer Cell Int 18, 73 (2018). https://doi.org/10.1186/s12935-018-0564-5
Published:
DOI: https://doi.org/10.1186/s12935-018-0564-5